SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-013101
Filing Date
2019-01-22
Accepted
2019-01-18 20:35:03
Documents
7
Period of Report
2019-01-17
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d693777d8k.htm 8-K 30337
2 EX-1.1 d693777dex11.htm EX-1.1 213062
3 EX-1.2 d693777dex12.htm EX-1.2 207678
4 EX-3.1 d693777dex31.htm EX-3.1 78713
5 EX-4.1 d693777dex41.htm EX-4.1 6511
6 EX-5.1 d693777dex51.htm EX-5.1 11040
7 GRAPHIC g693777dsp103.jpg GRAPHIC 3531
  Complete submission text file 0001193125-19-013101.txt   553756
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 19534095
SIC: 2834 Pharmaceutical Preparations